Perspective Therapeutics CATX
NYSE CATX
$2.73 -0.02 (-0.73%)
As of: Oct 1, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Return on Equity [ROE] (2011 - 2026)

Updated

Perspective Therapeutics' Return on Equity [ROE] came in at -34.98% for Q2 2026, up 0.82 percentage points from -35.80% a year earlier and up 5.57 percentage points from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Perspective Therapeutics' Return on Equity [ROE] was -41.96%, up 2.52 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of +9.46 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -44.49% in FY2024 (+27.16 pp), -71.65% in FY2023 (-53.08 pp), -18.56% in FY2022 and -9.26% in FY2021 (+42.16 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q1 2025.
  • Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -4.05 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2024 (a gain of 27.19 percentage points), and the weakest in Q4 2023 (a drop of 34.32 percentage points).
  • Business Quant data shows CATX's Return on Equity [ROE] at -40.56% (Q1 2026), -46.49% (Q4 2025) and -43.06% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Perspective Therapeutics 312.60 Mn 312.60 Mn - -34.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.98%
Mar 31, 2026 -40.56%
Dec 31, 2025 -46.49%
Sep 30, 2025 -43.06%
Jun 30, 2025 -35.80%
Mar 31, 2025 -30.50%
Dec 31, 2024 -26.29%
Sep 30, 2024 -18.77%
Jun 30, 2024 -20.34%
Mar 31, 2024 -38.00%
Dec 31, 2023 -53.47%
Sep 30, 2023 -20.90%
Jun 30, 2023 -13.58%
Mar 31, 2023 -7.37%
Dec 31, 2022 -13.06%
Sep 30, 2022 -15.29%
Jun 30, 2022 -11.68%
Mar 31, 2022 -9.80%
Dec 31, 2021 -8.69%
Sep 30, 2021 -7.38%
API Access

Perspective Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY